Health Care Investigations
In government investigations into pharmaceutical, biotechnology, medical device, and insurance company conduct, our health care consultants bring a unique breadth of data-related expertise, including hands-on knowledge of numerous data sources; access to proprietary data; and experience in analyzing data from clinical trials, FDA spontaneous reports, health insurance claims, and plaintiff medical records. Our teams have assessed economic and financial issues related to alleged violations of the False Claims Act; Anti-Kickback Statute; Food, Drug, and Cosmetic Act; and Foreign Corrupt Practices Act (FCPA).
Please visit our government investigations and qui tam litigation page for more information.
-
Case Outcome
Studies of Adverse Events
-
Video
Paul Greenberg - Pharmaceutical Off-Label Promotion
-
Case Outcome
US Department of Justice v. Tenet Healthcare Corporation
-
Case Outcome
Pharmaceutical Off-Label Promotion & Kickbacks Settlements
-
Case Outcome
GlaxoSmithKline Holdings (Americas) Inc. v. Commissioner of the IRS
-
Health Care Bulletin
Behind the Headlines in Pharmaceutical Investigations